<DOC>
	<DOCNO>NCT01092988</DOCNO>
	<brief_summary>The first magnetic resonance-guided focus ultrasound ( MRgFUS ) treatment uterine fibroid use ExAblate 2000 system perform 2001 . Since , 5000 treatment do 60 different hospital around world . The experience accumulate novel treatment collect InSightec implement software hardware update , clinical tip guideline , aim improve clinical result durability , maintain high level safety . Based extensive clinical experience internal research development effort goal toward continuous improvement ExAblate treatment safety performance , limited change make current ExAblate system . This modify ExAblate system version designate ExAblate 2100 UF V2 system . The modification believe improve system 's friendliness user , without introduce new risk issue safety device , negative impact safety technical efficacy treatment patient .</brief_summary>
	<brief_title>A Clinical Study Evaluate Safety ExAblate 2100 UF V2 System Treatment Symptomatic Uterine Fibroids</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>1 . Women age 18 old 2 . Symptomatic uterine fibroid , define result score 21 high , base patient response question 18 Uterine Fibroid Symptom HealthRelated Quality Life Questionnaire ( UFSQOL ) . 3 . Women give write informed consent 4 . Women able willing attend study visit 5 . Patient pre perimenopausal ( within 12 month last menstrual period ) 6 . Able communicate sensation ExAblate procedure . 7 . Uterine fibroid , device accessible 8 . Fibroid ( ) clearly visible noncontrast MRI . 9 . Fibroid ( ) enhance MR contrast image 1 . Women pregnant , confirmed serum/urine test time screening , urine pregnancy test day treatment 2 . Uterine size &gt; 24 week 3 . Patients breastfeed 4 . Patients active pelvic inflammatory disease ( PID ) . 5 . Patients active local systemic infection 6 . Contraindication MRI Scan : 1 . Severe claustrophobia would prevent completion procedure MR unit 2 . Weight great 250 IBS ( 113Kg ) 3 . Implanted ferromagnetic material and/or device contraindicate MR scan 4 . Known intolerance MRI contrast agent ( e.g . Gadolinium Magnevist ) 5 . Any contraindication MRI Scan 7 . Extensive abdominal scarring beam path 8 . Dermoid cyst obstruct treatment path . 9 . Known pelvic malignant premalignant condition 10 . Intrauterine device ( IUD ) anywhere treatment path</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Uterine Fibroids</keyword>
	<keyword>Bleeding</keyword>
	<keyword>Pain</keyword>
	<keyword>Quality life</keyword>
	<keyword>MR guide focus ultrasound</keyword>
</DOC>